Outcomes of patients treated with dabrafenib and trametinib who developed pyrexia syndrome and severe/complicated pyrexia syndrome.

Authors: Justin Komisarof, Jayesh Menon, Aryn Andrzejewski, Deborah A. Mulford

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e24092

Source: Full article

---

Abstract

e24092